Otsuka Holdings Co.,Ltd.
Notification of Completion of Share Repurchase and Number of Treasury Stock to be Cancelled
Filed with TSE ·
6ix is reading this filing.
View original source (TDnet)Otsuka Holdings Co., Ltd. on 6ix
Earlier from Otsuka
- Otsuka Presents Final Phase 3 VISIONARY Results for VOYXACT at ASN
- Otsuka Completes Rolling Submission of Supplemental Biologics License Application (sBLA) for Traditional Approval of VOYXACT in U.S.
- NDA Submission Initiated for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation NSCLC for Review Under FDA RTOR Program
- Notice regarding the status of share repurchases
- Otsuka Announces Transformative Phase 3 FUSION Results for Ulefnersen, Bringing the FUS-ALS Community Closer to a Potential Targeted Treatment
Follow Otsuka into a list and get an email when it puts out news.
Follow Otsuka